ACYLOXYALKYL CARBAMATE PRODRUGS, METHODS
    8.
    发明申请
    ACYLOXYALKYL CARBAMATE PRODRUGS, METHODS 审中-公开
    ACYLOXYALKYL CARBAMATE PRODRUGS,方法

    公开(公告)号:US20090234138A1

    公开(公告)日:2009-09-17

    申请号:US12473112

    申请日:2009-05-27

    IPC分类号: C07D207/12 C07C271/22

    摘要: The disclosures herein relate generally to acyloxyalkyl carbamate prodrugs of (±)-4-amino-3-(4-chlorophenyl)butanoic acid and analogs thereof, pharmaceutical compositions thereof, methods of making prodrugs of (±)-4-amino-3-(4-chlorophenyl)butanoic acid and analogs thereof, methods of using prodrugs of (±)-4-amino-3-(4-chlorophenyl)butanoic acid and analogs thereof, and pharmaceutical compositions thereof for treating or preventing common diseases and/or disorders such as spasticity and/or acid reflux disease. The disclosures herein also relate to acyloxyalkyl carbamate prodrugs of (±)-4-amino-3-(4-chlorophenyl)butanoic acid and analogs thereof which are suitable for oral administration and to sustained release oral dosage forms thereof.

    摘要翻译: 本文的公开内容通常涉及(±)-4-氨基-3-(4-氯苯基)丁酸及其类似物的氨基氧基烷基氨基甲酸酯前药,其药物组合物,制备(±)-4-氨基-3- (4-氯苯基)丁酸及其类似物,使用(±)-4-氨基-3-(4-氯苯基)丁酸及其类似物的前药的方法及其药物组合物,用于治疗或预防常见疾病和/或 疾病如痉挛和/或酸反流疾病。 本文的公开内容还涉及适于口服给药的(±)-4-氨基-3-(4-氯苯基)丁酸及其类似物的氨氧基烷基氨基甲酸酯前药及其缓释口服剂型。

    Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
    9.
    发明授权
    Acyloxyalkyl carbamate prodrugs, methods of synthesis and use 有权
    氨基甲酸氨基甲酸烷基酯前药,合成和使用方法

    公开(公告)号:US07572830B2

    公开(公告)日:2009-08-11

    申请号:US11923507

    申请日:2007-10-24

    IPC分类号: A61K31/235

    摘要: The disclosures herein relate generally to acyloxyalkyl carbamate prodrugs of (±)-4-amino-3-(4-chlorophenyl)butanoic acid and analogs thereof, pharmaceutical compositions thereof, methods of making prodrugs of (±)-4-amino-3-(4-chlorophenyl)butanoic acid and analogs thereof, methods of using prodrugs of (±)-4-amino-3-(4-chlorophenyl)butanoic acid and analogs thereof, and pharmaceutical compositions thereof for treating or preventing common diseases and/or disorders such as spasticity and/or acid reflux disease. The disclosures herein also relate to acyloxyalkyl carbamate prodrugs of (±)-4-amino-3-(4-chlorophenyl)butanoic acid and analogs thereof which are suitable for oral administration and to sustained release oral dosage forms thereof.

    摘要翻译: 本文的公开内容通常涉及(±)-4-氨基-3-(4-氯苯基)丁酸及其类似物的氨基氧基烷基氨基甲酸酯前药,其药物组合物,制备(±)-4-氨基-3- (4-氯苯基)丁酸及其类似物,使用(±)-4-氨基-3-(4-氯苯基)丁酸及其类似物的前药的方法及其药物组合物,用于治疗或预防常见疾病和/或 疾病如痉挛和/或酸反流疾病。 本文的公开内容还涉及适于口服给药的(±)-4-氨基-3-(4-氯苯基)丁酸及其类似物的氨氧基烷基氨基甲酸酯前药及其缓释口服剂型。